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Purpose or Objective: Four-dimensional cone-beam 
computed tomography (4D-CBCT) has great capability to 
provide volumetric and respiratory motion information with 
one gantry rotation. It is necessary to quantitatively assess, 
how difference of tumor displacement between actual and 
4D-CBCT image exists. In this study, we evaluated the 
displacement of implanted fiducial markers assumed as 
tumor on fluoroscopic projection images and reconstructed 
4D-CBCT images with different sorting methods.  
 
Material and Methods: We have developed 4D-CBCT utilizing 
dual source kV X-ray imaging subsystems. Five lung cancer 
patients with two to four implanted fiducial markers were 
enrolled in the institutional review board-approved trial. 
Each patient underwent three consecutive 4D-CBCT imaging. 
For at least two scans out of three, the imaging parameters 
were 110 kV, 160 mA and 5 ms, the rotational speed of the 
gantry was 1.5°/s, rotation time was 70 s, the image 
acquisition interval was 0.3°, and the rotational angle of 
105°. A marker that located the most nearest to the lung 
tumor was used for surrogate respiratory signal. The marker 
motion in superior-inferior (SI) direction was used as 
surrogate respiratory signal for 4D-CBCT image 
reconstruction. Surrogate respiratory signal were converted 
eight phase bins with retrospective amplitude- or phase- 
based sorting. On reconstructed 4D-CBCT images, the marker 
was contoured on all phases to detect its 3D positions. 
Meanwhile, the marker positions on two fluoroscopic images 
obtained simultaneously were converted to 3D position. 
Evaluation was employed among the displacement on 
fluoroscopic image (dfluoro), that on amplitude-based sorting 
4D-CBCT (da-4DCBCT) and that on phase-based sorting 4D-
CBCT (dp-4DCBCT) in left-right (LR), anterior-posterior (AP), 
and SI direction. Difference between da-4DCBCT and dfluoro 
(Da-f), and difference between dp-4DCBCT and dfluoro (Dp-f) 
were obtained for all patients.  
 
Results: Depending on the sorting methods, the positional 
difference was up to 2 mm on 4D-CBCT images. Overall mean 
± standard deviation of Da-f and Dp-f in LR, AP, and SI 
direction were -1.5±1.2, -2.9±1.2, -5.1±1.6 mm and -1.4±1.1, 
-2.3±0.9, -5.2±1.2 mm, respectively (Table 1). 4D-CBCT 
underestimated displacement of marker by 5 mm on average 
in SI direction.  
 
 
Conclusion: We performed displacement evaluation of 
fiducial markers on 4D-CBCT with two sorting methods. Since 
4D-CBCT requires convolution of marker motion in eight bins, 
underestimation of 5 mm on average was observed in SI 
direction.  
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Purpose or Objective: Image registration of Digitally 
Reconstructed Radiographs (DRRs) and real-time kV images is 
the only clinically implemented solution to markerless tumor 
tracking. However, registration still suffers from poor soft 
tissue visibility, restricting the workflow to only a certain size 
and density of tumors. The purpose of this study is to 
evaluate the feasibility of markerless tumor tracking on a 
clinical system through 4D/3D registration and the use of 
dual-energy (DE) imaging. 
 
Material and Methods: For 3 patients treated for NSCLC with 
dynamic tracking on the Vero SBRT system, on average 90 
soft-tissue enhanced DE images were created from sequential 
low- (LE) and high-energy (HE) orthogonal fluoroscopy. All DE 
images were binned in either inhale, exhale, maximum inhale 
or maximum exhale, using the amplitude of the synchronous 
external breathing signal.  
For each respective breathing phase, DRR templates were 
created from the 4D planning CT using the open-source 
Insight Toolkit (itk).  
As such, the localization problem was reduced to 2D/2D 
registration of 2 orthogonal kV images and 2 DRRs.  
Before registration, the currently implanted marker was 
removed on all images so to not bias the results.  
Intensity-based 2D/2D registration was carried out between 
each DE image and the respective DRR. The same was done 
with all HE images to evaluate the benefit of using DE 
imaging..  
The implanted marker was recovered and used as a 
benchmark to quantify the accuracy of the tumor 
localization. The mean Euclidean distance between the 
center of the marker in the DE and HE images, and the center 
of the marker in the matched DRR template was defined as 
the tracking error (TE). 
 
